Terms: = Breast cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA
35 results:
1. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
[TBL] [Abstract] [Full Text] [Related]
2. Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients.
Pan B; Xu Y; Yao R; Cao X; Zhou X; Hao Z; Zhang Y; Wang C; Shen S; Luo Y; Zhu Q; Ren X; Kong L; Zhou Y; Sun Q
J Transl Med; 2023 Nov; 21(1):798. PubMed ID: 37946210
[TBL] [Abstract] [Full Text] [Related]
3. Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial.
Calsavara VF; Henry NL; Hays RD; Kim S; Luu M; Diniz MA; Gresham G; Cecchini RS; Yothers G; Ganz PA; Rogatko A; Tighiouart M
Cancer Prev Res (Phila); 2023 Nov; 16(11):631-639. PubMed ID: 37756580
[TBL] [Abstract] [Full Text] [Related]
4. Primary pulmonary epithelioid hemangioendothelioma.
Jang YC; Hung WC; Su TC; Wu WP
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37709495
[TBL] [Abstract] [Full Text] [Related]
5. Neratinib is a TFEB and tfe3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells.
Bellese G; Tagliatti E; Gagliani MC; Santamaria S; Arnaldi P; Falletta P; Rusmini P; Matteoli M; Castagnola P; Cortese K
Biochem Pharmacol; 2023 Jul; 213():115633. PubMed ID: 37269887
[TBL] [Abstract] [Full Text] [Related]
6. An MRI-Based Radiomics Nomogram to Distinguish Ductal Carcinoma In Situ with Microinvasion From Ductal Carcinoma In Situ of breast cancer.
Wu Z; Lin Q; Wang H; Wang G; Fu G; Bian T
Acad Radiol; 2023 Sep; 30 Suppl 2():S71-S81. PubMed ID: 37211478
[TBL] [Abstract] [Full Text] [Related]
7. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
Caliskan S; Akar OS; Gun S; Kefeli M
Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
[TBL] [Abstract] [Full Text] [Related]
8. Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative breast cancer by Activating TFEB- and tfe3-Mediated Lysosome Biogenesis and Autophagy.
Soleimani M; Somma A; Kaoud T; Goyal R; Bustamante J; Wylie DC; Holay N; Looney A; Giri U; Triplett T; Dalby K; Kowalski J; Eckhardt SG; Van Den Berg C
Mol Cancer Ther; 2022 Oct; 21(10):1547-1560. PubMed ID: 35977156
[TBL] [Abstract] [Full Text] [Related]
9. NUPR1 promotes the proliferation and migration of breast cancer cells by activating tfe3 transcription to induce autophagy.
Xiao H; Long J; Chen X; Tan MD
Exp Cell Res; 2022 Sep; 418(1):113234. PubMed ID: 35660538
[TBL] [Abstract] [Full Text] [Related]
10. Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis.
Koopaie M; Kolahdooz S; Fatahzadeh M; Manifar S
Cancer Med; 2022 Jul; 11(13):2644-2661. PubMed ID: 35315584
[TBL] [Abstract] [Full Text] [Related]
11. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet Oncol; 2022 Mar; 23(3):382-392. PubMed ID: 35123662
[TBL] [Abstract] [Full Text] [Related]
12. Folliculin impairs breast tumor growth by repressing tfe3-dependent induction of the Warburg effect and angiogenesis.
El-Houjeiri L; Biondini M; Paquette M; Kuasne H; Pacis A; Park M; Siegel PM; Pause A
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779410
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset.
Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A
Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740
[TBL] [Abstract] [Full Text] [Related]
14. Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy.
Wu Q; Tian AL; Durand S; Aprahamian F; Nirmalathasan N; Xie W; Liu P; Zhao L; Zhang S; Pan H; Carmona-Gutierrez D; Madeo F; Tu Y; Kepp O; Kroemer G
Cell Death Dis; 2020 Nov; 11(11):1015. PubMed ID: 33243998
[TBL] [Abstract] [Full Text] [Related]
15. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
16. breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract] [Full Text] [Related]
17. Computer assisted recognition of breast cancer in biopsy images via fusion of nucleus-guided deep convolutional features.
George K; Sankaran P; K PJ
Comput Methods Programs Biomed; 2020 Oct; 194():105531. PubMed ID: 32422473
[TBL] [Abstract] [Full Text] [Related]
18. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
Anwar T; Rufail ML; Djomehri SI; Gonzalez ME; Lazo de la Vega L; Tomlins SA; Newman LA; Kleer CG
Mod Pathol; 2020 Aug; 33(8):1537-1545. PubMed ID: 32152520
[TBL] [Abstract] [Full Text] [Related]
19. Primary Thyroid Gland Alveolar Soft Part Sarcoma.
Whaley RD; Thompson LDR
Head Neck Pathol; 2020 Sep; 14(3):701-706. PubMed ID: 31782115
[TBL] [Abstract] [Full Text] [Related]
20. Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters.
Giannotti C; Zoppoli G; Ferrando L; Murialdo R; Caffa I; Laudisio A; Scabini S; Romairone E; Fregatti P; Friedman D; Odetti P; Nencioni A; Ballestrero A; Monacelli F
J Geriatr Oncol; 2020 May; 11(4):610-616. PubMed ID: 31706829
[TBL] [Abstract] [Full Text] [Related]
[Next]
